Pacific Biosciences of California
PACB
$2.33+1.30%
End of day · as of Oct 10, 2026, 5:30 AM ET
Mkt cap
$387.11M
EV/Sales
2.02
P/E ratio
N/A
FY2025 Revenue
$160.00M
EPS (TTM)
$-0.42
Gross Margin (FY2025)
28.61%
Profit Margin (FY2025)
-341.47%
Beta
2.10
Div yield
N/A
Sector
Healthcare
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Latest reported PACB revenue for 2025-12-31 was $160.0M. Net income was -$546.4M. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. PACB currently screens at market cap $387.1M.
Use this PACB research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full PACB income, balance, and cash tables.
Pacific Biosciences of California (PACB) is a medical devices company in the Healthcare sector.
Latest cached Pacific Biosciences of California (PACB) revenue for Dec 31, 2025 was $160.0M. Net income was -$546.4M. Statements: https://lician.com/financials/pacb
Pacific Biosciences of California (PACB) market capitalization is $387.1M on the latest cached snapshot.
Pacific Biosciences of California (PACB) cached previous close $2.30; day range $2.21 – $2.47; volume 12,782,916. Session quote: https://lician.com/quote/pacb
Pacific Biosciences of California (PACB) latest cached earnings event is "PACB earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached PACB filing is 8-K · Jul 9, 2026. Filings: https://lician.com/sec/pacb